Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AtriCure, Inc.ATRC · Entity 2704 | Director | May 07, 2018 | May 09, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AtriCure, Inc.
Report date May 07, 2018 · Filed May 09, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,967 |
Ending reported balance
After 2018-05-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-05-07 · Exercise / conversion · Acquired 10,000 · Balance 29,967 Row 2 · 2018-05-08 · Sale · Disposed 10,000 · Balance 19,967 F1: This transaction was executed in multiple trades at prices ranging from $22.63 to $22.97 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.30 · Expires 2023-05-23 | Direct | 0 |
Reported balance
After 2018-05-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-05-07 · Exercise / conversion · Disposed 10,000 · Balance 0 F2: These options were granted on May 23, 2013 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $22.63 to $22.97 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: These options were granted on May 23, 2013 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2018 Filed May 9, 2018 13:00 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 10,000 | $22.82 | $228,200.00 |
DisclosureSEC source: 0001209191-18-028735 · doc4.xml · nonDerivative · entry 2 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,967 F1 · price: This transaction was executed in multiple trades at prices ranging from $22.63 to $22.97 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 07, 2018 Filed May 9, 2018 13:00 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-18-028735 · doc4.xml · derivative · entry 3 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 23, 2013 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| May 07, 2018 Filed May 9, 2018 13:00 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 10,000 | $9.30 | $93,000.00 |
DisclosureSEC source: 0001209191-18-028735 · doc4.xml · nonDerivative · entry 1 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 20:34 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 10,000 | $20.00 | $200,000.00 |
DisclosureSEC source: 0001209191-18-019568 · doc4.xml · nonDerivative · entry 2 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,967 F1 · price: This transaction was executed in multiple trades at prices ranging from $19.88 to $20.15 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 20:34 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $14.17 | $0.00 |
DisclosureSEC source: 0001209191-18-019568 · doc4.xml · derivative · entry 3 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 18, 2011 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 20:34 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 10,000 | $14.17 | $141,700.00 |
DisclosureSEC source: 0001209191-18-019568 · doc4.xml · nonDerivative · entry 1 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 13:08 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 10,000 | $22.40 | $224,000.00 |
DisclosureSEC source: 0001209191-17-049892 · doc4.xml · nonDerivative · entry 2 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,967 F1 · price: This transaction was executed in multiple trades at prices ranging from $22.35 to $22.52 per share. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 13:08 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $8.04 | $0.00 |
DisclosureSEC source: 0001209191-17-049892 · doc4.xml · derivative · entry 3 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 15, 2012 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 13:08 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 10,000 | $8.04 | $80,400.00 |
DisclosureSEC source: 0001209191-17-049892 · doc4.xml · nonDerivative · entry 1 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2017 Filed May 25, 2017 20:41 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 5,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035439 · doc4.xml · nonDerivative · entry 1 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,967 F1 · security: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. Read SEC document |
| May 17, 2017 Filed May 17, 2017 20:35 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 10,000 | $21.44 | $214,400.00 |
DisclosureSEC source: 0001209191-17-033108 · doc4.xml · nonDerivative · entry 2 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,162 F1 · price: This transaction was executed in multiple trades at prices ranging from $21.37 to $21.65 per share. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 16, 2017 Filed May 17, 2017 20:35 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.10 | $0.00 |
DisclosureSEC source: 0001209191-17-033108 · doc4.xml · derivative · entry 3 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2018-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 28, 2008 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| May 16, 2017 Filed May 17, 2017 20:35 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 10,000 | $10.10 | $101,000.00 |
DisclosureSEC source: 0001209191-17-033108 · doc4.xml · nonDerivative · entry 1 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2016 Filed Nov 16, 2016 21:20 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 10,000 | $19.73 | $197,300.00 |
DisclosureSEC source: 0001209191-16-150515 · doc4.xml · nonDerivative · entry 2 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,162 F1 · price: This transaction was executed in multiple trades at prices ranging from $19.62 to $19.90 per share. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 21:20 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $9.50 | $0.00 |
DisclosureSEC source: 0001209191-16-150515 · doc4.xml · derivative · entry 3 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on June 20, 2007 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 21:20 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 10,000 | $9.50 | $95,000.00 |
DisclosureSEC source: 0001209191-16-150515 · doc4.xml · nonDerivative · entry 1 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2016 Filed Sep 14, 2016 20:27 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 6,000 | $15.93 | $95,580.00 |
DisclosureSEC source: 0001209191-16-141410 · doc4.xml · nonDerivative · entry 2 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,162 F1 · price: This transaction was executed in multiple trades at prices ranging from $15.76 to $16.23 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 20:27 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0001209191-16-141410 · doc4.xml · derivative · entry 3 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 19, 2010 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 20:27 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 10,000 | $5.15 | $51,500.00 |
DisclosureSEC source: 0001209191-16-141410 · doc4.xml · nonDerivative · entry 1 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.